EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 372 filers reported holding EXELIXIS INC in Q2 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,628 | +14.5% | 394,861 | +0.2% | 0.64% | +19.5% |
| Q2 2023 | $7,533 | -6.1% | 394,179 | -4.6% | 0.53% | -11.2% |
| Q1 2023 | $8,020 | +17.9% | 413,196 | -2.6% | 0.60% | +12.8% |
| Q4 2022 | $6,805 | -99.7% | 424,235 | +164.8% | 0.53% | +155.8% |
| Q3 2022 | $2,512,000 | -73.1% | 160,183 | -64.3% | 0.21% | -71.3% |
| Q2 2022 | $9,351,000 | -12.8% | 449,136 | -5.1% | 0.73% | +9.3% |
| Q1 2022 | $10,725,000 | – | 473,106 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |